Bristol Gate Capital Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-890
Closed -$203K 34
2021
Q4
$203K Buy
+890
New +$196K 0.01% 33
2021
Q3
Sell
-399,165
Closed -$84.9M 32
2021
Q2
$84.9M Buy
399,165
+28,215
+8% +$5.96M 4.45% 14
2021
Q1
$75.8M Buy
370,950
+1,605
+0.4% +$316K 4.52% 11
2020
Q4
$67.2M Buy
369,345
+13,447
+4% +$2.29M 4.46% 11
2020
Q3
$59.5M Buy
355,898
+42,030
+13% +$7.08M 4.5% 12
2020
Q2
$51M Buy
+313,868
New +$56.3M 4.34% 22

Other funds holding CME

Bristol Gate Capital Partners's CME Position: Q1 2022 in Review

Bristol Gate Capital Partners sold out of CME Group (CME) in Q1 2022, closing a stake of 890 shares — an estimated $203K sold.

Bristol Gate Capital Partners first reported a position in CME in Q2 2020 and held it in 6 quarters. The position peaked at $84.9M in Q2 2021. 1,183 funds tracked by Wall St. Rank hold CME as of Q1 2022.

  • Bristol Gate Capital Partners reported no remaining CME Group position as of Q1 2022 after selling out during the quarter.
  • Bristol Gate Capital Partners sold 890 CME Group shares in Q1 2022, an estimated $203K.
  • Bristol Gate Capital Partners first reported a position in CME Group in Q2 2020 and held it in 6 quarters.
  • Bristol Gate Capital Partners's CME Group position peaked at $84.9M in Q2 2021.
  • 1,183 funds tracked by Wall St. Rank held CME Group as of Q1 2022.

Based on Bristol Gate Capital Partners's 13F filing for Q1 2022, filed 12 May 2022.